Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
MiMedx Group, Inc. MDXG
$6.10
+$0.08 (1.33%)
На 18:00, 12 мая 2023
+31.15%
Потенциал через год
Ранг: 4
Ключевые показатели
-
Marketcap
698230040.00000000
-
week52high
6.42
-
week52low
2.43
-
Revenue
267841000
-
P/E TTM
-26705
-
Beta
1.54982600
-
EPS
-0.33000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 июл 2023 г. в 10:59
Описание компании
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 14 сент 2021 г. |
| Northland Capital Markets | Outperform | 26 июл 2021 г. | |
| HC Wainwright & Co. | Buy | 19 мар 2021 г. | |
| Lake Street | Hold | Buy | 26 февр 2018 г. |
| Needham | Hold | Strong Buy | 20 февр 2018 г. |
| HC Wainwright & Co. | Buy | Buy | 07 сент 2022 г. |
| Mizuho | Buy | 13 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Capper Joseph H | A | 3600000 | 3600000 | 27 янв 2023 г. |
| Carlson Peter M | D | 565206 | 4992 | 22 дек 2022 г. |
| Newton Todd | A | 325618 | 200000 | 15 сент 2022 г. |
| Stein Robert Benjamin | D | 278673 | 8329 | 13 сент 2022 г. |
| Stein Robert Benjamin | D | 287002 | 19000 | 12 сент 2022 г. |
| Stein Robert Benjamin | D | 306002 | 8503 | 12 авг 2022 г. |
| Kashyap Rohit | D | 430072 | 12343 | 09 авг 2022 г. |
| Stein Robert Benjamin | D | 314505 | 19500 | 04 авг 2022 г. |
| Stein Robert Benjamin | D | 334005 | 14600 | 28 июн 2022 г. |
| Giuliani Michael J | A | 94770 | 44191 | 10 июн 2022 г. |
Новостная лента
MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Call Transcript
Seeking Alpha
02 мая 2023 г. в 23:08
MiMedx Group, Inc. (NASDAQ:MDXG ) Q1 2023 Earnings Conference Call May 2, 2023 5:00 PM ET Company Participants Matt Notarianni - Head, IR Joe Capper - CEO Pete Carlson - CFO Conference Call Participants Anthony Petrone - Mizuho Group Carl Byrnes - Northland Capital Markets Swayampakula Ramakanth - H.C. Wainwright John Vandermosten - Zacks Operator Good afternoon and thank you for standing by.
MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2
GlobeNewsWire
18 апр 2023 г. в 08:00
MARIETTA, Ga., April 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that it will report operating and financial results for the first quarter ended March 31, 2023 after the market close on Tuesday, May 2, 2023. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 5:00 p.m. Eastern Time on the same day.
MiMedx Group, Inc. (MDXG) Q4 2022 Earnings Call Transcript
Seeking Alpha
28 февр 2023 г. в 22:46
MiMedx Group, Inc. (NASDAQ:MDXG ) Q4 2022 Results Conference Call February 28, 2023 5:00 PM ET Company Participants Matt Notarianni - Head, IR Joe Capper - CEO Pete Carlson - CFO Conference Call Participants Anthony Petrone - Mizuho Group Carl Byrnes - Northland Capital Markets Swayampakula Ramakanth - H.C. Wainwright John Vandermosten - Zacks Operator Good afternoon, and thank you for standing by.
MiMedx Group, Inc. (MDXG) Q3 2022 Earnings Call Transcript
Seeking Alpha
02 ноя 2022 г. в 22:32
MiMedx Group, Inc. (NASDAQ:MDXG ) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Matt Notarianni – Head-Investor Relations Todd Newton – Interim Chief Executive Officer Pete Carlson – Chief Financial Officer Rohit Kashyap – President-Wound and Surgical Robert Stein – President-Regenerative Medicine Conference Call Participants Anthony Petrone – Mizuho Group RK – H.C. Wainwright Carl Byrnes – Northland Capital John Vandermosten – Zacks Operator Good afternoon and thank you for standing by.